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This study investigates the competitive adsorption potential of activated carbon prepared from 
cherry kernels (CScPA) to remove sulfamethoxazole, carbamazepine, ketoprofen, naproxen, 
diclofenac and ibuprofen from aqueous solution. The effect of operational parameters 
including initial pH, adsorbent dose, contact time and initial pharmaceutical concentration 
were studied in batch adsorption experiments. The results indicate that CScPA can be used as 
an alternative, effective and low-cost adsorbent that presents basis of sustainable technology 
for efficient pharmaceuticals wastewater remediation and decontamination. 
 
Introduction 
In recent years, the presence of pharmaceuticals and personal care products (PPCPs) 
discharged into the water environment has been recognized as one of the common emerging 
issues worldwide because their residues may damage or have other adverse effects on the 
environmental ecology [1]. Pharmaceutical antibiotic sulfamethoxazole (SMX) is produced in 
large quantities and extensively used in the farming industry as veterinary therapeutics and 
growth promoters [2]. Diclofenac (DCF) and carbamazepine (CBZ) are two of the most 
frequently detected pharmaceutical residues in aquatic environments. DCF is a non-steroidal 
anti-inflammatory drug (NSAIDs) commonly used for the treatment of arthritis, whilst CBZ is 
an antiepileptic drug used for the treatment of psychomotor and temporal lobe epilepsy and 
also for the treatment of trigeminal neuralgia [3]. Ketoprofen (KP) is a non-steroidal anti-
inflammatory drug, widely used for the treatment of rheumatoid arthritis, osteoarthritis, 
ankylosing spondylitis, and also for non-rheumatoid diseases or postoperative pain [4]. 
Naproxen (NPX) is a member of the arylacetic acid group that exhibits anti-inflammatory and 
analgesic effects in medical treatments [5]. Ibuprofen (IBP) is one of the most highly utilized 
NSAIDs worldwide and therefore it has been one of the most commonly detected 
pharmaceuticals in the environment, with concentrations up to micrograms per liter [6]. 
Recently there has been a growing concern about the elimination of pharmaceutical 
compounds from wastewater, and technologies studied include photo-catalytic degradation 
[7], biodegradation [8], biofiltration [9] and membrane filtration [10]. Advanced oxidation 
processes and other chemical treatments, can break down organic molecules into simple 
compounds, but they have many disadvantages; for instance, the high capital and operational 
cost and possible generation of secondary pollutions resulting in high disposal costs [11]. In 
contrast, adsorption technique is one of the preferred methods due to its simplicity as well as 
the availability of wide range of adsorbents. The cost of adsorption technology application can 
be reduced, if the adsorbent is cheap. Previous studies have revealed adsorption of PPCPs onto 
various adsorbents, such as activated carbon [12–14], carbon nanotubes [15], mesoporous 
nanocomposite [16] and agricultural waste[17,18]. 




So far, activated carbon is the widely used adsorbent for the removal of PPCPs. In recent years 
growing research interest in the production of low-cost and highly efficient activated carbons. 
The suitable application of activated carbon depends on its properties which vary with used 
raw precursor and preparation technique [19]. Recently, activated carbons are derived from 
relatively cheap and effective raw materials with a high carbon and low inorganic content, 
such as agro-industrial wastes, fruit industry waste and various solid organic substances for a 
lower adsorption system cost. 
In the current study, the green activated carbon from fruit processing industry waste 
(cherry/sweet cherry kernels) was investigated for PPCPs removal capacity from aqueous 
solutions following batch experiments. The effects of pH (2-9), adsorbent dosage (0.04-4 g/L), 
initial concentration of PPCPs in the solution (1-50 mg/L) and contact time (5-300 min) were 
evaluated. The goal of this work is to evaluate the performance of the CScPA for the 
competitive removal of PPCPs from aqueous wastes and to simulate complex pollutant 
conditions encountered in wastewater treatment plant influent. 
 
Experimental 
About 140,000 tons of sweet and sour cherry are produces in Serbia every year. Because of 
that prepared activated carbon was made from sour cherry/sweet cherry kernels which were 
washed with distilled water, crushed and dried. Phosphoric acid (50 wt.%) was used for 
thermochemical impregnation. Further procedure is shown in previously work [20]. 
Five PPCPs (CBZ, DCF, NPX, KP and IBP) were purchased from Sigma–Aldrich (Germany) 
while SMX was purchased from Fluka (Buchs, Switzerland). Water used for all standards 
were milli-Q prepared with Easypure II, Thermo Scientific. The stock solutions containing of 
SMX, CBZ, DCF, NPX, KP and IBP were prepared dissolving standards with 10 mL of water 
(milli-Q) and then 10 mL acetonitrile (HPLC grade, Sigma-Aldrich, Germany). After that 10 
mL of 0.05% CH3COOH, 250 mL of glacial CH3COOH (Zorka Pharma, Serbia), diluted in 
volumetric flask of 500 mL filled with milli-Q water, and another 10 mL of acetonitrile were 
added. Standard solution concentration of pharmaceuticals was determined by HPLC (High 
Performance Liquid Chromatography, Agilent 1200 series). 
Pharmaceuticals in filtered solution were detected by previously described chromatographic 
technique. The principle is states the separation and quantification of pharmaceuticals using 
XDB-C18 column and mobile phase, acidic solution with acetonitrile, with detection at 
various wave length. Separation was achieved with a type-C18 chromatography column 
(Zorbax Eclipse XDB-C18, 4.6 mm x 150 mm, particle size 5 μm); flow rate: 1 mL/min; 
column temperature: 30°C; injection volume: 15 μL; mobile phase: 0,05% CH3COOH: 
acetonitrile (HPLC grade, Sigma-Aldrich, Germany) = 55:45; run time = 18 min; detection: 
280, 220, 230 and 254 nm [21]. 
Adsorption tests were performed by shaking the flasks at 140 rpm for fixed time using 
mechanical stirrer Heidolph Unimax 1010 (Germany) in order to achieve equilibrium. The 
mixtures were then filtered through Fioroni qualitative filter paper (Grade 115) and residual 
concentrations of pharmaceuticals were measured using HPLC. Two important equations are 
used to calculate amount of adsorbed pharmaceuticals on activated carbon qe (mg/g) and to 
determine percent of removal of pharmaceuticals from solution Re (%): 
qe =
(C0 − Ce) ∙ V
m




∙ 100                                                                                                                   (2) 




Where C0 is the initial pharmaceutical concentration (mg/L) and Ce is the pharmaceutical 
concentration at equilibrium (mg/L), V is the volume of solution (L) and m is the mass of 
activated carbon (g). 
The effect of pH on pharmaceutical adsorption onto CScPA was investigated as 
following procedure: 0.1 g (2.0 g/L) of CScPA were added to 50 mL solution using initial 
concentration of 10 mg/L of each pharmaceutical for 60 min at room temperature (22±1 °C). 
In order to study the effect of pH on pharmaceutical adsorption, the initial pH of the solutions 
varied from 2 to 9, by adding appropriate amounts of diluted NH4OH and HCl solutions.  
Influence of activated carbon dosage was studied by using CScPA concentration ranging 
from 2, 10, 20, 50, 80, 100, 150, 200 mg, (0.04-4 g/L) in 50 mL solution of 10 mg/l each 
pharmaceutical at optimal pH 6, for contact time of 60 min. Whole experiment was done at 
room temperature (22±1 °C).  
The effect of contact time was studied at various time intervals (5, 15, 30, 60, 120, 180, 
240, 300 min) with initial concentration of 10 ml/L of each pharmaceutical at pH 6.0 and room 
temperature (22±1 °C). In 50 ml solution CScPA dose was 0.1 g (2.0 g/L). 
In order to assess the effect of pharmaceutical concentration on adsorption efficiency, 
initial adsorbate concentrations were varied at 1, 2, 5, 10, 20, 30, 40, 50 mg/L of each 
pharmaceutical with optimal pH (6.0), CScPA dose of 0.1 g (2.0 g/L), contact time 60 min at 
temperature (22±1 °C). 
 
Results and discussion 
Fig. 1a shows the effect of pH on the removal of pharmaceutical into CScPA for different pH 
values. Generally, the adsorption of pharmaceuticals depends strongly on the pH of the 
solution [22]. From the Fig. 1a, it may be concluded that the retention of pharmaceuticals after 
adsorption onto CScPA is remarkably influenced by the pH. This parameter has very 
important role in adsorption process and in particular on the adsorption capacity [23]. In fact, 
the adsorption efficiency of SMX, CBZ, DCF, NPX, KP and IBP decreases when pH was 
increased from 6 to 9. The pKa of KP, NPX, DCF and IBP are 4.45, 4.2, 4.15, 4.91, 
respectively, when pH is above pKa, acidic pharmaceuticals have negative charge while 
surface of adsorbent becomes more negatively charged, leading to an electrostatic repulsion 
between them. The pKa1 and pKa2 of SMX are 1.6 and 5.7 which indicates that this molecule 
has zero charge which indicates that there is no electrostatic bonding. CBZ has pKa 13.9 
showing that it has a positive charge leading to potential electrostatic interaction between 
pharmaceuticals and surface groups of the CScPA. 
Adsorption of acidic PPCPs decrease gradually for basic pH values. Dissociation degree of the 
surface functional groups and PPCPs is high, so the adsorbent and the solutes KP, NPX, DCF 
and IBP are in their negatively charged forms. In case of CBZ, it’s neutral compound in the 
pH tested range; its binding onto CScPA is solely attributable to a non-electrostatic interaction 
involving hydrogen bonding probably through a nitrogen groups, oxygen groups of esters, 
carbonyl groups from aldehyde and ketones, methyl groups for hydrophobic bonding and Van 
der Waals interactions [24]. 
Adsorption efficiency is strongly affected by the adsorbent dosage, due to availability of the 
surface area and exchangeable sites. Fig. 1b presents results of the experiments with varying 
activated carbon concentrations. With the increase of activated carbon mass, from 2 mg to 200 
mg, (0.04 - 4 g/L), the amount of adsorbed SMX, CBZ, DCF, NPX, KP and IBP decreases 
from 17.87 to 2.72 mg/g, 84.40 to 2.49 mg/g, 39.70 to 2.59 mg/g, 21.33 to 2.73 mg/g, 21.11 to 
3.35 mg/g, 38.99 to 2.44 mg/g, respectively. After dosage of 2.0 g/L, the removal efficiency 




was not increased rapidly. This dosage was adopted because the aim was to find optimal 
removal efficiency, while retaining minimal operating costs, for economic application for 
wastewater treatment plant.  
The effect of contact time on the adsorption of SMX, CBZ, DCF, NPX, KP and IBP on the 
CScPA is presented in Fig. 1c. It is revealed, as expected, that increasing in contact time 
increased removal of PPCPs. In the first step of adsorption over 85% of pharmaceuticals are 
bounded in first 15 min and in the second phase equilibrium is attained within 60 min. It is 
easy to spot fast adsorption of every pharmaceutical on CScPA. CBZ showed in Fig. 1c 
represents that contact time is not strictly correlated with the adsorbate removal, because of its 
molecule nature. The amount of adsorbed pharmaceutical increased with time at initial stage 
of adsorption and after some point in time almost remained constant. Dynamic equilibrium 
was reached by the amount of adsorption from adsorbent, at this point. The time required to 
attain the state of equilibrium is termed the equilibrium time, and the amount of 
pharmaceutical adsorbed at the equilibrium time reflects the maximum adsorption capacity of 




Figure 1. Effect of pH (a), adsorbent concentration (b), contact time (c) and initial 
concentrations (d) of SMX, CBZ, KP, NPX, DCF and IBP onto adsorption process 
 
Varying pharmaceutical concentrations of 1-50 mg/L on optimal conditions showed 
decreasing in removal efficiency, for every pharmaceutical it was almost the same, up to 10 
mg/L. After that, the removal efficiency was slightly decreasing up to 30mg/L, after which it 
decreased significantly. In whole process (Fig. 1d) of adsorption SMX, CBZ, DCF, NPX, KP 
and IBP removal efficiency dropped from 98.35 to 75.92%, 98.88 to 85.99%, 98.70 to 
78.91%, 98.38 to 81.02%, 98.98 to 84.93%, 97.90 to 82.25%, respectively. Decrease in 
predicted process efficiency may be attributed to the lack of sufficient adsorption sites on 
surface area to accommodate more pharmaceutical available in the solution. Initial 
concentration of pharmaceuticals effected adsorption rate and capacity. Necessary driving 




force was supplied by minimized mass transfer of initial concentration. In general, initial 
concentration boosts the adsorption of pharmaceuticals irrespective of the nature of adsorbent 
surface such as microporous, mesoporous, negatively or positively charge surface The 
concentration increases the accessibility of pores for adsorbate molecules, as well as 
interactions at solid–liquid interface [26]. 
 
Conclusion 
This paper describes the adsorption of six pharmaceuticals (SMX, CBZ, KP, NPX, DCF and 
IBP) onto green activated carbon CScPA in multi-solute solutions. The batch adsorption 
experiments showed that the optimal operation conditions at 140 rpm, pH 6.0, CScPA dosage 
2 mg/L and contact time 60 min have removal efficiency over 95 % for SMX, CBZ, KP, NPX, 
DCF and IBP. According to obtained results, the CScPA was found to be a promising low-cost 
solution for PPCPs contaminated water remediation and decontamination. 
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